Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.
Saved in:
| Title: | Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders. |
|---|---|
| Authors: | Sabdia MB; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia. Electronic address: m.bilalsabdia@mater.uq.edu.au., Patch AM; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. Electronic address: ann-marie.patch@qimrberghofer.edu.au., Tsang H; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia. Electronic address: hennes.tsang@uq.net.au., Gandhi MK; Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address: maher.gandhi@mater.uq.edu.au. |
| Source: | Blood reviews [Blood Rev] 2022 Nov; Vol. 56, pp. 100969. Date of Electronic Publication: 2022 May 06. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
